Showing 471-480 of 846 results for "".
The Placebo and Nocebo Effects in Dermatology
https://practicaldermatology.com/columns/clinical-focus-1/the-placebo-and-nocebo-effects-in-dermatology/23559/Increasing evidence suggests that these effects—though not fully understood—may be harnessed for patient care.Assessment of Superficially-placed Microaliquots of Small-particle HA
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/assessment-of-superficially-placed-microaliquots-of-small-particle-ha/23611/A prospective, open-label clinical trial assesses micro-injections of transparent hyaluronic acid gel for cheek rejuvenation.Journal Club: Tapinarof Cream in Pediatric Patients
https://practicaldermatology.com/programs/Practical-Dermatology-Atopic-Dermatitis-Journal-Club/journal-club-tapinarof-cream-in-pediatric-patients/32399/Practical Dermatology Editorial Board member Peter Lio, MD, speaks with Mona Shahriari, MD, about the Journal of Dermatology article "A phase 2, randomized, double-blind, vehicle-controlled trial of tapinarof cream in Japanese pediatric patients with atopic dermatitis," and the general importance ofDr. Goldberg Discusses Experience with the VariLite Laser
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/dr-goldberg-discusses-experience-with-gemini-laser/19468/“One of the great things about being in the laser field is there are new lasers that come out every day. It makes it a very exciting arena to be in. The problem is the popular machine of today, unfortunately, often becomes the machine that you don't need a year from now. The VariLite is tried andAnalyzing Safety Data From Level Up
https://practicaldermatology.com/series/the-practical-dermatology-podcast/analyzing-safety-data-from-level-up/33944/The latest news and updates, plus Matthew Zirwas, MD, FAAD, joins Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, to discuss the importance of the Week 16 safety data from the Level Up study on upadacitinib. Silverberg JI, Bunick CG, et al. Efficacy and safety of upadacitinib versuWebsite Rankings of Dermatology Associations; News and Trends
https://practicaldermatology.com/youngmd-connect/resident-resource-center/website-rankings-of-dermatology-associations-news-and-trends/20854/Biologics and Pediatric Psoriasis
https://practicaldermatology.com/topics/practice-management/biologics-and-pediatric-psoriasis/21196/Though data has been lacking in recent years, the use of biologics in pediatric and adolescent patients deserves more consideration.Therapeutics Focus: Skin Cancer
https://practicaldermatology.com/topics/skin-cancer-photoprotection/therapeutics-focus-skin-cancer/21419/New products and pharmacologic developmentsTo Attenuate the Skin Cancer Epidemic, Start Early
https://practicaldermatology.com/topics/skin-cancer-photoprotection/to-end-the-skin-cancer-epidemic-start-early/20719/UV education and good SPF habits for children are essential to reversing worrisome skin cancer trends.New Oral Agent May Shift Psoriasis Treatment Landscape
https://practicaldermatology.com/topics/psoriasis/new-oral-agent-may-shift-psoriasis-treatment-landscape/21258/A notable approval in 2014, apremilast may play an important role in bridging a wide gap in the care of moderate to severe psoriasis.